Companies primarily engaged in the research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering. Includes companies specializing in protein-based therapeutics to treat human diseases. Excludes companies manufacturing products using biotechnology but without a health care application.
The Biotechnology industry has on average risen 47% over the last 3 months. The average price/earnings ratio is 94.7 and the average return on equity is 21%. These averages are based on an equal weighting of the 15 most liquid stocks in this industry.
Symbol | Company Name | Setup | TA | FA | CRS | % Chg | 1 Month | 3 Month | 6 Month | PE | Market Cap | Vol(50) | Action |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 80.36 | 0% | 5.04% | 21.44% | 21.59% | 21.49 | 346.25B | 488.06 | ||||
| AMG.DE | AMGEN INC | 12.67 | -0.5% | 8.62% | -3.15% | 2.69% | 13.35 | 135.02B | 762.52 | ||||
| 1GILD.MI | GILEAD SCIENCES INC | 0 | 7.86% | -0.56% | 17.96% | 42.04% | 15.87 | 131.38B | 298.08 | ||||
| GIS.DE | GILEAD SCIENCES INC | 79.13 | 0.15% | 9.23% | 5.22% | 14.82% | 15.56 | 128.80B | 639.04 | ||||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 10.21 | -0.16% | 13.78% | -7.71% | -14.33% | 25.3 | 94.65B | 107.72 | ||||
| ARGX.BR | ARGENX SE | 93.21 | 0.37% | 14.48% | 39.29% | 31.02% | 94.7 | 43.38B | 114.14K | ||||
| 1AE.DE | ARGENX SE | 0 | -0.43% | 8.9% | N/A | N/A | 94.35 | 43.22B | N/A | ||||
| 22UA.DE | BIONTECH SE-ADR | 12.42 | 0.22% | 8.87% | -6.72% | -11.02% | N/A | 21.89B | 41.09K | ||||
| IDP.DE | BIOGEN INC | 16.7 | 1.85% | 10.34% | 16.28% | 24.84% | 9.4 | 19.01B | 581.84 | ||||
| 0QF.DE | MODERNA INC | 2.86 | 1.72% | 11.43% | -19.63% | -5.63% | N/A | 9.01B | 32.52K | ||||
| 1MRNA.MI | MODERNA INC | 1.81 | -3.92% | 10% | -20.97% | 0.78% | N/A | 8.85B | 10.89K | ||||
| 1EXEL.MI | EXELIXIS INC | 0 | -8.49% | N/A | N/A | N/A | 17.15 | 8.26B | N/A | ||||
| 2X1.DE | ABIVAX SA | 0 | 0% | 13.94% | N/A | N/A | N/A | 6.17B | N/A | ||||
| ABVX.PA | ABIVAX SA | 99.71 | 0% | 12.66% | 38.95% | 1202.63% | N/A | 6.16B | 88.03K | ||||
| 1AKRO.MI | AKERO THERAPEUTICS INC | 0 | Infinity% | N/A | N/A | N/A | N/A | 3.66B | N/A | ||||
| 22Z.DE | ZEALAND PHARMA A/S | 0 | 0.16% | 5.81% | N/A | N/A | 4.9 | 2.87B | N/A | ||||
| 1SRPT.MI | SAREPTA THERAPEUTICS INC | 0 | -4.8% | N/A | N/A | N/A | N/A | 2.04B | N/A | ||||
| GLPG.AS | GALAPAGOS NV | 37.32 | -0.86% | -1.77% | 2.28% | 18.89% | N/A | 1.82B | 107.30K | ||||
| AZT.OL | ARCTICZYMES TECHNOLOGIES ASA | 96.96 | 0% | 17.19% | 66.21% | 78.57% | 1000 | 1.53B | 32.77K | ||||
| TRMED.OL | THOR MEDICAL ASA | 98.09 | -1.69% | -2.74% | 42.86% | 47.92% | N/A | 1.23B | 3.89M |